Physician profile
Mark A Grevious
NPI 1194727909
$27,962.00
in general payments reported to CMS, 2019-2025
12 companies · $55.46 in 2025
The $55.46 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2021: $146 · 2022: $84.32 · 2023: $19K · 2024: $8,570 · 2025: $55.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Consulting Fee: $4,430 · Travel and Lodging: $3,396 · Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $14,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Consulting Fee | $4,430.00 |
| Travel and Lodging | $3,395.99 |
| Food and Beverage | $799.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $26,479.74 | 2021-2024 | Recell |
| Medtronic, INC. | $875.00 | 2023 | |
| Mentor Worldwide LLC | $162.18 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Acelrx Pharmaceuticals, INC. | $108.25 | 2021 | |
| Axogen | $83.08 | 2019-2024 | Avance Nerve Graft |
| Polynovo North America LLC | $72.43 | 2021-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $47.36 | 2022 | |
| Depuy Synthes Sales INC. | $36.96 | 2022 | |
| Smith+Nephew, INC. | $34.06 | 2019 | |
| Solventum Corporation | $32.79 | 2025 | V.A.C.Instill |
| Kerecis Limited | $19.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Musculoskeletal Transplant Foundation INC. | $10.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Grevious listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.